Bayer faces multiple challenges in Africa, where it is pursuing its interests in genetically modified crops and importing pesticides that are controversial.
Higher interest rates, tightening monetary policy, persistent inflation, global macro uncertainty, and more stringent bank conditions have roiled the global capital markets and made investing ...
Sign up for our free newsletter and receive the latest banking and fintech stories, straight to your inbox - every week
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
